Detalhe da pesquisa
1.
Aged neutrophils accumulate in lymphoid tissues from healthy elderly mice and infiltrate T- and B-cell zones.
Immunol Cell Biol
; 96(8): 831-840, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29603362
2.
Lipid-laden partially-activated plasmacytoid and CD4(-)CD8α(+) dendritic cells accumulate in tissues in elderly mice.
Immun Ageing
; 11: 11, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25089147
3.
IL-2/CD40-driven NK cells install and maintain potency in the anti-mesothelioma effector/memory phase.
Int Immunol
; 24(6): 357-68, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-22354912
4.
Prognostic role of immune environment in luminal B early breast cancer.
Cancer Med
; 12(7): 8278-8288, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36751105
5.
Intratumoral interleukin-2/agonist CD40 antibody drives CD4+ -independent resolution of treated-tumors and CD4+ -dependent systemic and memory responses.
Cancer Immunol Immunother
; 61(4): 549-60, 2012 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-22002241
6.
Chemotherapy broadens the range of tumor antigens seen by cytotoxic CD8(+) T cells in vivo.
Cancer Immunol Immunother
; 61(12): 2343-56, 2012 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-22714286
7.
Aging Leads to Increased Monocytes and Macrophages With Altered CSF-1 Receptor Expression and Earlier Tumor-Associated Macrophage Expansion in Murine Mesothelioma.
Front Aging
; 3: 848925, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35821822
8.
The STING agonist, DMXAA, reduces tumor vessels and enhances mesothelioma tumor antigen presentation yet blunts cytotoxic T cell function in a murine model.
Front Immunol
; 13: 969678, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36466911
9.
Deliberately provoking local inflammation drives tumors to become their own protective vaccine site.
Int Immunol
; 20(11): 1467-79, 2008 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-18824504
10.
CD8+ cytotoxic T cell responses to dominant tumor-associated antigens are profoundly weakened by aging yet subdominant responses retain functionality and expand in response to chemotherapy.
Oncoimmunology
; 8(4): e1564452, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30906657
11.
Photophysical and biological investigation of phenol substituted rhenium tetrazolato complexes.
Dalton Trans
; 48(41): 15613-15624, 2019 Nov 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31408065
12.
Microenvironment-Dependent Gradient of CTL Exhaustion in the AE17sOVA Murine Mesothelioma Tumor Model.
Front Immunol
; 10: 3074, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31998326
13.
The Regulatory Status Adopted by Lymph Node Dendritic Cells and T Cells During Healthy Aging Is Maintained During Cancer and May Contribute to Reduced Responses to Immunotherapy.
Front Med (Lausanne)
; 5: 337, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30560130
14.
Macrophage Depletion in Elderly Mice Improves Response to Tumor Immunotherapy, Increases Anti-tumor T Cell Activity and Reduces Treatment-Induced Cachexia.
Front Genet
; 9: 526, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30459812
15.
Elderly dendritic cells respond to LPS/IFN-γ and CD40L stimulation despite incomplete maturation.
PLoS One
; 13(4): e0195313, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29652910
16.
Modulation of dendritic cell and T cell cross-talk during aging: The potential role of checkpoint inhibitory molecules.
Ageing Res Rev
; 38: 40-51, 2017 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-28736117
17.
A review of the importance of immune responses in luminal B breast cancer.
Oncoimmunology
; 6(3): e1282590, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28405507
18.
Aging and cancer: The role of macrophages and neutrophils.
Ageing Res Rev
; 36: 105-116, 2017 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-28390891
19.
Human mesothelioma induces defects in dendritic cell numbers and antigen-processing function which predict survival outcomes.
Oncoimmunology
; 5(2): e1082028, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-27057464
20.
Murine mesothelioma induces locally-proliferating IL-10(+)TNF-α(+)CD206(-)CX3CR1(+) M3 macrophages that can be selectively depleted by chemotherapy or immunotherapy.
Oncoimmunology
; 5(6): e1173299, 2016 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-27471652